Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Cipher Pharmaceuticals Inc T.CPH

Alternate Symbol(s):  CPHRF

Cipher Pharmaceuticals Inc. is a specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products, mainly in dermatology. The Company acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products in Canada, the United States, and South America. Its dermatology products include Actikerall, Epuris, and Vaniqa. Its hospital acute care products include Aggrastat and Brinavess. Its out-licensed products include Absorica, ConZip and Lipofen. Durela is its specialty medicine. Its product pipeline includes MOB-015, CF-101, and DTR-001. It delivers novel products to healthcare professionals and patients in Canada in a range of therapeutic areas, including dermatology, women’s health, urology and others. It also has the Natroba operations and global product rights to Natroba and its authorized generic Spinosad, a topical treatment for both head lice and scabies.


TSX:CPH - Post by User

Comment by PitchinPennieson Jan 15, 2021 7:36pm
225 Views
Post# 32311989

RE:RE:RE:Wow! Total incompetence!!!

RE:RE:RE:Wow! Total incompetence!!!Sure, I'd be happy to tell you. In fact, let me take this opportunity to reiterate -- surely without gloating -- what I've been telling the three or four delusional cheerleaders on this board (no disrespect intended here, Pabs) that when you have an Interim CEO who is certified as the Stupidest Man in the World, every development that follows will not be necessarily positive. If you're serious about the class-action suit, count me in. Pabs, you are a colourful character, and I'll miss seeing your hopeful posts about how the sugar-plum fairy is coming to deliver you a pile of cash in the form of Trulance arbitration, but there are plenty of other fish in the sea. I hope you didn't get hurt too bad placing your trust in Craig Mull, but the man is a pipsqueak who probaly still thinks he can run a public company, even after this latest in a string of debacles. You're right to get out Monday, Pabs. The arbitration is going to result in Mull writing a cheque to Bausch for $5 million. As Nelson says in each episode of The Simpsons, "Haw-haw!" 
<< Previous
Bullboard Posts
Next >>